Award

(NU/1433-36) IndigoDX Ltd: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation

NEWCASTLE UNIVERSITY

This public procurement record has 1 release in its history.

Award

30 Sep 2022 at 10:32

Summary of the contracting process

The Newcastle University has awarded a contract for the commercialisation of university research to DU Biosciences. The project involves creating a diagnostic tool for urinary symptoms caused by an overactive bladder to improve treatment outcomes. The procurement process was completed under a selective procurement method, with a cancelled status. The value of the contract signed on 6th September 2022 is £30,000.

This tender presents business growth opportunities for high-tech start-ups with experience in securing seed investment and establishing manufacturing facilities. Companies in the business and management consultancy sector may find this opportunity suitable. The University is seeking a driven executive to lead the project, build a compelling investment proposition, and establish collaborative research projects to advance the technology.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

(NU/1433-36) IndigoDX Ltd: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation

Notice Description

1 in 5 adults in the UK suffer from urinary symptoms caused by an overactive bladder (OAB). Symptoms include urgency (a sudden compelling desire to pass urine, which cannot be deferred), increased frequency of voiding (both day and night) and urge incontinence (involuntary leakage accompanied by / immediately preceded by urgency). The Team wishes to establish a spinout company to produce a Dipstick-style test. Our discovery is currently being developed into a simple-to-use diagnostic tool used for (1) regular screening for OAB in adults, at a GP surgery, pharmacy or nursing home, and (2) to assess the effectiveness of treatments (companion diagnostic) and modifying dosing/treatments accordingly. Accurate and early diagnosis will improve treatment outcomes, eliminating the need for patients to have invasive and high-risk surgery-led second-line treatments necessary for advanced-stage disease. Currently there is no competition for a non-invasive biomarker-based test, and new product development activity appears to be very limited, suggesting an opportunity for 'first mover advantage' and to establish a standard. We require a driven executive to take this technology forward and build a compelling proposition for investment. The Executive will need to create a robust business model that is acceptable to the founders, develop and deliver pitch materials for investors and establish collaborative research projects. The executive appointed should have an appropriate background, ideally with experience of high tech starts ups, securing seed investment and establishing manufacturing facilities.

Lot Information

Lot 1

1 in 5 adults in the UK suffer from urinary symptoms caused by an overactive bladder (OAB). Symptoms include urgency (a sudden compelling desire to pass urine, which cannot be deferred), increased frequency of voiding (both day and night) and urge incontinence (involuntary leakage accompanied by / immediately preceded by urgency). The Team wishes to establish a spinout company to produce a Dipstick-style test. Our discovery is currently being developed into a simple-to-use diagnostic tool used for (1) regular screening for OAB in adults, at a GP surgery, pharmacy or nursing home, and (2) to assess the effectiveness of treatments (companion diagnostic) and modifying dosing/treatments accordingly. Accurate and early diagnosis will improve treatment outcomes, eliminating the need for patients to have invasive and high-risk surgery-led second-line treatments necessary for advanced-stage disease. Currently there is no competition for a non-invasive biomarker-based test, and new product development activity appears to be very limited, suggesting an opportunity for 'first mover advantage' and to establish a standard. We require a driven executive to take this technology forward and build a compelling proposition for investment. The Executive will need to create a robust business model that is acceptable to the founders, develop and deliver pitch materials for investors and establish collaborative research projects. The executive appointed should have an appropriate background, ideally with experience of high tech starts ups, securing seed investment and establishing manufacturing facilities.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0371b3
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/027450-2022
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Dynamic
Procurement Category
Services
Procurement Method
Selective
Procurement Method Details
Restricted procedure
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security


CPV Codes

79400000 - Business and management consultancy and related services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£30,000 Under £100K

Notice Dates

Publication Date
30 Sep 20223 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
5 Sep 20223 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NEWCASTLE UNIVERSITY
Additional Buyers

DURHAM UNIVERSITY

EUROPEAN UNION

NORTHUMBRIA UNIVERSITY NEWCASTLE NEWCASTLE

TEESSIDE UNIVERSITY

UNIVERSITY OF BATH ON BEHALF OF THE SETSQUARED

UNIVERSITY OF SUNDERLAND

Contact Name
Mrs Natalie Morton
Contact Email
cheryl.holmstrom@sunderland.ac.uk, david.pratt@tees.ac.uk, edwin.e.milligan@durham.ac.uk, hugh.rhodes@northumbria.ac.uk, natalie.morton@ncl.ac.uk, pb487@bath.ac.uk
Contact Phone
+44 1912086396

Buyer Location

Locality
NEWCASTLE
Postcode
NE1 7RU
Post Town
Newcastle upon Tyne
Country
England

Major Region (ITL 1)
TLC North East (England)
Basic Region (ITL 2)
TLC4 Northumberland, Durham and Tyne & Wear
Small Region (ITL 3)
TLC43 Tyneside
Delivery Location
TLC North East (England)

Local Authority
Newcastle upon Tyne
Electoral Ward
Monument
Westminster Constituency
Newcastle upon Tyne Central and West

Supplier Information

Number of Suppliers
1
Supplier Name

DU BIOSCIENCES

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0371b3-2022-09-30T11:32:35+01:00",
    "date": "2022-09-30T11:32:35+01:00",
    "ocid": "ocds-h6vhtk-0371b3",
    "initiationType": "tender",
    "tender": {
        "id": "DN621227",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "(NU/1433-36) IndigoDX Ltd: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "79400000",
            "description": "Business and management consultancy and related services"
        },
        "mainProcurementCategory": "services",
        "description": "1 in 5 adults in the UK suffer from urinary symptoms caused by an overactive bladder (OAB). Symptoms include urgency (a sudden compelling desire to pass urine, which cannot be deferred), increased frequency of voiding (both day and night) and urge incontinence (involuntary leakage accompanied by / immediately preceded by urgency). The Team wishes to establish a spinout company to produce a Dipstick-style test. Our discovery is currently being developed into a simple-to-use diagnostic tool used for (1) regular screening for OAB in adults, at a GP surgery, pharmacy or nursing home, and (2) to assess the effectiveness of treatments (companion diagnostic) and modifying dosing/treatments accordingly. Accurate and early diagnosis will improve treatment outcomes, eliminating the need for patients to have invasive and high-risk surgery-led second-line treatments necessary for advanced-stage disease. Currently there is no competition for a non-invasive biomarker-based test, and new product development activity appears to be very limited, suggesting an opportunity for 'first mover advantage' and to establish a standard. We require a driven executive to take this technology forward and build a compelling proposition for investment. The Executive will need to create a robust business model that is acceptable to the founders, develop and deliver pitch materials for investors and establish collaborative research projects. The executive appointed should have an appropriate background, ideally with experience of high tech starts ups, securing seed investment and establishing manufacturing facilities.",
        "lots": [
            {
                "id": "1",
                "description": "1 in 5 adults in the UK suffer from urinary symptoms caused by an overactive bladder (OAB). Symptoms include urgency (a sudden compelling desire to pass urine, which cannot be deferred), increased frequency of voiding (both day and night) and urge incontinence (involuntary leakage accompanied by / immediately preceded by urgency). The Team wishes to establish a spinout company to produce a Dipstick-style test. Our discovery is currently being developed into a simple-to-use diagnostic tool used for (1) regular screening for OAB in adults, at a GP surgery, pharmacy or nursing home, and (2) to assess the effectiveness of treatments (companion diagnostic) and modifying dosing/treatments accordingly. Accurate and early diagnosis will improve treatment outcomes, eliminating the need for patients to have invasive and high-risk surgery-led second-line treatments necessary for advanced-stage disease. Currently there is no competition for a non-invasive biomarker-based test, and new product development activity appears to be very limited, suggesting an opportunity for 'first mover advantage' and to establish a standard. We require a driven executive to take this technology forward and build a compelling proposition for investment. The Executive will need to create a robust business model that is acceptable to the founders, develop and deliver pitch materials for investors and establish collaborative research projects. The executive appointed should have an appropriate background, ideally with experience of high tech starts ups, securing seed investment and establishing manufacturing facilities.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Ability to meet the required programme",
                            "type": "quality",
                            "description": "Pass / Fail"
                        },
                        {
                            "name": "Confirm acceptance of the formal appointment to the board milestone requirements",
                            "type": "quality",
                            "description": "Pass / Fail"
                        },
                        {
                            "name": "Quality: Ability to meet the Job Description required for the individual",
                            "type": "quality",
                            "description": "70"
                        },
                        {
                            "name": "Equity share",
                            "type": "quality",
                            "description": "5"
                        },
                        {
                            "type": "price",
                            "description": "25"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKC"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "selective",
        "procurementMethodDetails": "Restricted procedure",
        "techniques": {
            "hasDynamicPurchasingSystem": true
        },
        "reviewDetails": "The University will incorporate a standstill period at the point information on the award of the contract is communicated to tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the contract is entered into. The Public Contracts Regulations 2015 (SI 2015 No 102) provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England, Wales and Northern Ireland) within 30 days of knowledge or constructive knowledge of breach."
    },
    "awards": [
        {
            "id": "027450-2022-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-64819",
                    "name": "DU Biosciences"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-168",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "streetAddress": "Newcastle University, Procurement Services, Kingsgate",
                "locality": "Newcastle",
                "region": "UKC",
                "postalCode": "NE1 7RU",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Mrs Natalie Morton",
                "telephone": "+44 1912086396",
                "email": "natalie.morton@ncl.ac.uk"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "url": "https://www.ncl.ac.uk",
                "buyerProfile": "https://www.ncl.ac.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "09",
                        "description": "Education"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-169",
            "name": "Durham University",
            "identifier": {
                "legalName": "Durham University"
            },
            "address": {
                "locality": "The Palatine Centre, Stockton Road",
                "region": "UKC",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "Edwin.e.milligan@durham.ac.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.durham.ac.uk"
            }
        },
        {
            "id": "GB-FTS-64818",
            "name": "Northumbria University Newcastle Newcastle",
            "identifier": {
                "legalName": "Northumbria University Newcastle Newcastle"
            },
            "address": {
                "locality": "Newcastle upon Tyne",
                "region": "UKC",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "Hugh.Rhodes@northumbria.ac.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://northumbria.ac.uk"
            }
        },
        {
            "id": "GB-FTS-171",
            "name": "University of Sunderland",
            "identifier": {
                "legalName": "University of Sunderland"
            },
            "address": {
                "locality": "Sunderland",
                "region": "UKC",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "Cheryl.Holmstrom@sunderland.ac.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://Sunderland.ac.uk"
            }
        },
        {
            "id": "GB-FTS-38690",
            "name": "Teesside University",
            "identifier": {
                "legalName": "Teesside University"
            },
            "address": {
                "locality": "Middlesbrough, Tees Valley",
                "region": "UKC",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "David.Pratt@tees.ac.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.tees.ac.uk/"
            }
        },
        {
            "id": "GB-FTS-38691",
            "name": "University of Bath on behalf of the SETsquared",
            "identifier": {
                "legalName": "University of Bath on behalf of the SETsquared"
            },
            "address": {
                "locality": "Claverton Down, Bath",
                "region": "UK",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "pb487@bath.ac.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.bath.ac.uk/"
            }
        },
        {
            "id": "GB-FTS-172",
            "name": "European Union",
            "roles": [
                "funder"
            ]
        },
        {
            "id": "GB-FTS-64819",
            "name": "DU Biosciences",
            "identifier": {
                "legalName": "DU Biosciences"
            },
            "address": {
                "locality": "London",
                "region": "UKC",
                "postalCode": "SW19 1JG",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        },
        {
            "id": "GB-FTS-174",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "locality": "Tyne and Wear",
                "postalCode": "NE1 7RU",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        },
        {
            "id": "GB-FTS-1062",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "locality": "Tyne and Wear",
                "countryName": "United Kingdom"
            },
            "roles": [
                "mediationBody",
                "reviewContactPoint"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-168",
        "name": "Newcastle University"
    },
    "planning": {
        "budget": {
            "finance": [
                {
                    "id": "1",
                    "description": "Northern Accelerator programme involving funding from both the European Regional Development Funding (ERDF) and Research England",
                    "financingParty": {
                        "name": "European Union",
                        "id": "GB-FTS-172"
                    },
                    "relatedLots": [
                        "1"
                    ]
                }
            ]
        }
    },
    "contracts": [
        {
            "id": "027450-2022-1",
            "awardID": "027450-2022-1",
            "status": "active",
            "value": {
                "amount": 30000,
                "currency": "GBP"
            },
            "dateSigned": "2022-09-06T00:00:00+01:00"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "2",
                "measure": "smeBids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "3",
                "measure": "foreignBidsFromEU",
                "relatedLot": "1",
                "value": 0
            },
            {
                "id": "4",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "5",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 1
            }
        ]
    },
    "links": [
        {
            "rel": "prev",
            "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:528050-2022:TEXT:EN:HTML"
        }
    ],
    "language": "en"
}